A previous history of cancer cancer did not impact clinical outcomes in advanced lung cancer patients and these patients therefore should be considered for inclusion in clinical trials, according to a study .
The American Society for Radiation Oncology (ASTRO) has signaled their approval of the decision by the Centers for Medicare and Medicaid Services to provide coverage for annual lung cancer screening for those at very high risk for lung cancer.
Research indicates a high value of scans that could lead to future change of reimbursement policies for follow-up PET/CT studies in lung cancer.
The pioneering prostate cancer drug abiraterone can significantly extend the lives of men with advanced prostate cancer if administered prior to administering chemotherapy, according to phase III clinical trial data.
New research suggests that active surveillance may be an initial approach for men with favorable intermediate-risk prostate cancer.
A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.
A previously unrecognized action as a potent inhibitor of the dominant mutation that confers drug resistance to all well-tolerated treatments in patients with certain leukemia types has been found in Axitinib.
A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer.
Researchers have developed a device that uses electric fields to drive chemotherapy drugs through the protective barrier of tissue and directly into pancreatic tumors, preventing their growth.
- Cancer survivors need not be excluded from advanced stage lung cancer trials
- Fried food consumption associated with increased risk for heart failure
- Focus groups identify support needs of patients who smoke
- Twitter smoking cessation program helps smokers quit
- ASTRO applauds CMS decision to cover annual screening for high-risk lung cancer patients
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|